Inventor
SUN DAQING
US47 patents
⚠️ This page may combine multiple inventors who share the name “SUN DAQING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ORIC PHARMACEUTICALS INC
18 patentsUS11028120B2Jun 8, 2021
CD73 inhibitors
ORIC PHARMACEUTICALS INC10 citations93
US12018043B2Jun 25, 2024
CD73 inhibitors
ORIC PHARMACEUTICALS INC6 citations85
US11325938B2May 10, 2022
CD73 inhibitors
ORIC PHARMACEUTICALS INC9 citations85
US11530236B2Dec 20, 2022
CD73 inhibitors
ORIC PHARMACEUTICALS INC4 citations83
US11130778B2Sep 28, 2021
CD73 inhibitors
ORIC PHARMACEUTICALS INC8 citations83
US11129841B2Sep 28, 2021
CD73 inhibitors
ORIC PHARMACEUTICALS INC7 citations82
US10472387B2Nov 12, 2019
Inhibitors of glucocorticoid receptor
ORIC PHARMACEUTICALS INC2 citations73
US11377469B2Jul 5, 2022
CD73 inhibitors
ORIC PHARMACEUTICALS INC5 citations71
US12577272B2Mar 17, 2026
CD73 inhibitors
ORIC PHARMACEUTICALS INC0 citations62
US12454544B2Oct 28, 2025
CD73 inhibitors
ORIC PHARMACEUTICALS INC0 citations62
US11807658B2Nov 7, 2023
CD73 inhibitors
ORIC PHARMACEUTICALS INC1 citations62
US11576922B2Feb 14, 2023
CD73 inhibitors
ORIC PHARMACEUTICALS INC1 citations61
US11124537B2Sep 21, 2021
Inhibitors of glucocorticoid receptor
ORIC PHARMACEUTICALS INC1 citations61
US12544391B2Feb 10, 2026
CD73 inhibitors
ORIC PHARMACEUTICALS INC0 citations51
US11208432B2Dec 28, 2021
Inhibitors of glucocorticoid receptor
ORIC PHARMACEUTICALS INC0 citations51
US11110103B2Sep 7, 2021
Inhibitors of glucocorticoid receptor
ORIC PHARMACEUTICALS INC0 citations51
US10836789B2Nov 17, 2020
Inhibitors of glucocorticoid receptor
ORIC PHARMACEUTICALS INC0 citations51
US10723759B2Jul 28, 2020
Inhibitors of glucocorticoid receptor
ORIC PHARMACEUTICALS INC0 citations51
AMGEN INC
15 patentsUS7132438B2Nov 7, 2006
Benzimidazole derivatives
AMGEN INC62 citations94
US7524848B2Apr 28, 2009
Diaza heterocyclic amide compounds and their uses
AMGEN INC24 citations92
US9593129B2Mar 14, 2017
Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
AMGEN INC5 citations83
US9296736B2Mar 29, 2016
Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
AMGEN INC7 citations83
US9376425B2Jun 28, 2016
Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer
AMGEN INC12 citations82
US7402704B2Jul 22, 2008
Arylsulfones and uses related thereto
AMGEN INC3 citations62
US7635774B2Dec 22, 2009
Benzimidazole derivatives
AMGEN INC3 citations60
US7605289B2Oct 20, 2009
Benzamide derivatives and uses related thereto
AMGEN INC4 citations60
US7834047B2Nov 16, 2010
Arylsulfonamides and uses related thereto
AMGEN INC0 citations51
US7754890B2Jul 13, 2010
Arylsulfones and uses related thereto
AMGEN INC0 citations51
US7495012B2Feb 24, 2009
Arylsulfonamides and uses related thereto
AMGEN INC0 citations51
US7365075B2Apr 29, 2008
Aryl sulfonamide compounds and uses related thereto
AMGEN INC1 citations51
US11407721B2Aug 9, 2022
CIS-morpholinone and other compounds as MDM2 inhibitors for the treatment of cancer
AMGEN INC0 citations50
US11274105B2Mar 15, 2022
Alpha-hydroxy phenylacetic acid pharmacophore or bioisostere Mcl-1 protein antagonists
AMGEN INC0 citations48
US7825122B2Nov 2, 2010
Diaza heterocyclic sulfonamide derivatives and their uses
AMGEN INC0 citations41
POWERS JAY P
5 patentsUS8138190B2Mar 20, 2012
Diaza heterocyclic amide compounds and their uses
POWERS JAY P0 citations51
US8765788B2Jul 1, 2014
Tricyclic inhibitors of hydroxysteroid dehydrogenases
POWERS JAY P0 citations49
US8637576B2Jan 28, 2014
Benzamide derivatives and uses related thereto
POWERS JAY P0 citations48
US8076376B2Dec 13, 2011
Aniline sulfonamide derivatives and their uses
POWERS JAY P0 citations40
US8772296B2Jul 8, 2014
Benzamide derivatives and uses related thereto
POWERS JAY P0 citations37